ES8401049A1 - Procedimiento para la preparacion de n-acetil-tiazolidin-4-carboxilato de hexametilentetramina. - Google Patents

Procedimiento para la preparacion de n-acetil-tiazolidin-4-carboxilato de hexametilentetramina.

Info

Publication number
ES8401049A1
ES8401049A1 ES517348A ES517348A ES8401049A1 ES 8401049 A1 ES8401049 A1 ES 8401049A1 ES 517348 A ES517348 A ES 517348A ES 517348 A ES517348 A ES 517348A ES 8401049 A1 ES8401049 A1 ES 8401049A1
Authority
ES
Spain
Prior art keywords
hexamethylenetetramine
thiazolidine
carboxylate
acetyl
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES517348A
Other languages
English (en)
Other versions
ES517348A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ausonia Farmaceutici SRL
Original Assignee
Ausonia Farmaceutici SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ausonia Farmaceutici SRL filed Critical Ausonia Farmaceutici SRL
Publication of ES517348A0 publication Critical patent/ES517348A0/es
Publication of ES8401049A1 publication Critical patent/ES8401049A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D277/06Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE N-ACETIL-TIAZOLIDIN-4-CARBOXILATO DE HEXAMETILENTETRAMINA.CONSISTE EN LA REACCION DE ACIDO N-ACETIL-TIAZOLIDIN-4-CARBOXILICO Y DE HEXAMETILENTETRAMINA, EN CANTIDADES ESTEQUIOMETRICAS, EN DISOLVENTES POLARES, TALES COMO LOS ALCOHOLES INFERIORES, METANOL, ETANOL E ISOPROPANOL; Y EN AISLAR LA SAL OBTENIDA, DE FORMULA (I), MEDIANTE PRECIPITACION FORMADA POR ADICION DE DISOLVENTES APOLARES, TALES COMO ETER DIETILICO Y ETER DIISOPROPILICO.DE APLICACION FARMACOLOGICA PARA EL TRATAMIENTO DE LAS AFECCIONES BACTERIANAS DE LAS VIASURINARIAS E INTESTINALES Y PARA EL TRATAMIENTO DE LOS CATARROS VESICALES E INTESTINALES.
ES517348A 1982-03-01 1982-11-12 Procedimiento para la preparacion de n-acetil-tiazolidin-4-carboxilato de hexametilentetramina. Expired ES8401049A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8219900A IT1210859B (it) 1982-03-01 1982-03-01 Composto chemioterapico, procedimento per la sua preparazione e relative composizioni farmaceutiche.

Publications (2)

Publication Number Publication Date
ES517348A0 ES517348A0 (es) 1983-12-16
ES8401049A1 true ES8401049A1 (es) 1983-12-16

Family

ID=11162179

Family Applications (1)

Application Number Title Priority Date Filing Date
ES517348A Expired ES8401049A1 (es) 1982-03-01 1982-11-12 Procedimiento para la preparacion de n-acetil-tiazolidin-4-carboxilato de hexametilentetramina.

Country Status (13)

Country Link
US (1) US4469691A (es)
JP (1) JPS58148885A (es)
BE (1) BE894951A (es)
DE (1) DE3241473A1 (es)
ES (1) ES8401049A1 (es)
FR (1) FR2522326A1 (es)
GB (1) GB2115806A (es)
GR (1) GR77785B (es)
IT (1) IT1210859B (es)
LU (1) LU84465A1 (es)
NL (1) NL8204372A (es)
PT (1) PT75823A (es)
ZA (1) ZA828236B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6495366B1 (en) * 1999-09-03 2002-12-17 Therakos, Inc. Uninterrupted flow pump apparatus and method
US20060198886A1 (en) * 2005-03-01 2006-09-07 Jenkins Richard B Medicament having coated methenamine combined with acidifier

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6804994A (es) * 1967-04-11 1968-10-14
FR2204411B1 (es) * 1972-11-02 1976-03-05 Claude Dufour
US4001231A (en) * 1973-03-29 1977-01-04 William H. Rorer, Inc. Process for making a methenamine salt of an optically active acid

Also Published As

Publication number Publication date
LU84465A1 (fr) 1983-06-13
FR2522326A1 (fr) 1983-09-02
ES517348A0 (es) 1983-12-16
ZA828236B (en) 1983-09-28
PT75823A (en) 1982-12-01
IT8219900A0 (it) 1982-03-01
BE894951A (nl) 1983-03-01
DE3241473A1 (de) 1983-09-15
IT1210859B (it) 1989-09-29
JPS645596B2 (es) 1989-01-31
JPS58148885A (ja) 1983-09-05
NL8204372A (nl) 1983-10-03
GB2115806A (en) 1983-09-14
GR77785B (es) 1984-09-25
US4469691A (en) 1984-09-04

Similar Documents

Publication Publication Date Title
ES477591A1 (es) Procedimiento para la obtencion de preparados farmaceuticos que contienen un derivado de cefem.
ES8304143A1 (es) "procedimiento para la preparacion de derivados de cefem".
IL108382A0 (en) Amino acid derivatives, their preparation and pharmaceutical compositions containing them
ES8403897A1 (es) Procedimiento para la fabricacion de nuevos derivados de la amino-3 quinuclidina
ES476109A1 (es) Procedimiento para la preparacion de derivados de cefalospo-rina
IL107287A (en) Heterocyclic derivatives process for their preparation and pharmaceutical compositions containing some of them
NO155932C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive erytromycin-derivater.
SE8002322L (sv) Medel for behandling av inflammatoriska tarmsjukdomar
ES8706139A1 (es) Procedimiento para la fabricacion de nuevos derivados de la cumarina
AU6216586A (en) New tricyclic compounds, processes for the preparation thereof and pharmaceutical compositions containing them
ES8205759A1 (es) Un procedimiento para la preparacion de aminopropenol y pro-pano nitrilos 2 sustituidos.
ES8401049A1 (es) Procedimiento para la preparacion de n-acetil-tiazolidin-4-carboxilato de hexametilentetramina.
IL113744A0 (en) 3-Cephem derivatives and their preparation
DE3461378D1 (en) Rifamycins derivatives and preparation and pharmaceutical compositions thereof
ES8802612A1 (es) Procedimiento para preparar derivados de benzisoselenazolilo
ES472085A1 (es) Un procedimiento para la preparacion de una composicion te- rapeutica para el tratamiento de enfermedades alergicas.
IL57394A0 (en) Cephem derivatives and process for their manufacture
ES453501A1 (es) Un procedimiento para la preparacion de nuevos derivados n- metilenicos de tienamicina.
ES8308306A1 (es) Procedimiento de preparacion de derivados bencilidenicos.
ES2001893A6 (es) Procedimiento para la obtencion de derivados de metilendioxifenantreno
JPS55162785A (en) Novel xanthine derivative* its manufacture and allurgy therapeutic agent containing same
ES8605803A1 (es) Procedimiento para la fabricacion de nuevos compuestos cina-moicos
JPS57108087A (en) (4,5)-4h-benzo(1,2-b)cycloheptafuran derivative, manufacture and use as medicine
ES2002903A6 (es) Procedimiento para preparar derivados de cefalosporina
GB1527236A (en) Pharmaceutical compositions comprising substituted 3-cinnamoyl-2h-pyran-2,6(3h)-diones

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20001009